This announcement is a separate document:
泰凌醫藥:就延遲寄發截至2021年12月31日止年度年報授出豁免
NT PHARMA: GRANT OF WAIVER IN RELATION TO DELAY IN DESPATCH OFANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2021
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.